InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Grygiel Nancy A., Directeur. Officer active across 1 companies, notably AMGEN INC. Aggregated, 11 filings have been logged. The latest transaction was filed on 5 May 2022 — Retenue fiscale. Regulator: SEC (Form 4). The full history is free.
Declarations11 total
€11,64852 shares@ €224.00930.0000% mcap1.5% of flow
Common Stock
SEC:0001127602-22-013872:0·
0649 shares0
Common Stock
SEC:0001127602-22-013347:0·
€14,20460 shares@ €236.72930.0000% mcap1.8% of flow
Common Stock
SEC:0001127602-22-012761:0·
€74,373350 shares@ €212.49570.0000% mcap9.7% of flow
Common Stock
SEC:0001127602-22-010191:0·
01,001 shares0
Common Stock
SEC:0001127602-22-008134:0·
0935 shares0
Common Stock
SEC:0001127602-21-028756·
0935 shares0
Common Stock
SEC:0001127602-21-028756:0·
€334,7192,500 shares@ €133.8878100.0% of flow
Common Stock
SEC:0001127602-21-016446·
€334,7192,500 shares@ €133.88780.0002% mcap43.5% of flow
Common Stock
SEC:0001127602-21-016446:0·
0584 shares0
Common Stock
SEC:0001127602-21-015358:0·
0584 shares0
Common Stock
SEC:0001127602-21-015358·
11 of 11 declarations
About Grygiel Nancy A.
Nancy A. Grygiel is Senior Vice President and Chief Commercial Officer at Amgen Inc, a biopharmaceutical company. She plays a key role in business development and market strategy, contributing to the company's growth and impact in the healthcare sector.
